Cardiology Associations

This page includes news coverage of cardiology societies and associations. Follow these links for specific cardiology society news pages: American College of Cardiology (ACC), American Heart Association (AHA), American Society of Echocardiography (ASE), American Society Nuclear Cardiology (ASNC), European Society of Cardiology (ESC), Heart Rhythm Society (HRS), Society for Cardiovascular Angiography Interventions (SCAI), Society of Cardiovascular Computed Tomography (SCCT), Transcatheter Cardiovascular Therapeutics (TCT), and Vascular Interventional Advances (VIVA).

AI-based coronary plaque evaluations highlight elevated heart risks in women
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
Death after 1 year more common for real-world low-risk TAVR patients than those treated in clinical trials
Real-world patients were still associated with "excellent" outcomes, but it is important for cardiologists and patients alike to know as much as possible about the odds of survival following treatment.
No longer the ‘forgotten valve’: Tricuspid valve surgery outcomes keep improving
Patient outcomes after tricuspid valve replacement have improved significantly over the years, according to new data published in The Annals of Thoracic Surgery.
Implantable IVC sensor shows early potential to guide heart failure management
The goal is to measure changes in a patient’s IVC area and collapsibility, which can help anticipate when heart failure events might occur. This first-in-human study included data from the first 50 patients to receive the device.
New drug reverses antiplatelet effects of ticagrelor, helping surgeons avoid a 'bloody mess'
Deepak Bhatt, MD, believes bentracimab could be a game-changer if it gains approval. "I think it's the sort of drug that every emergency room and ICU would have to stock," he said. "A cardiac care unit would have to stock a couple of doses, as would every cath lab."

New drugs, updated treatment strategies: 5 important trends in cardiology from an eventful 2023

Revisit some of the year's biggest trends in the diagnosis, treatment and prevention of cardiovascular disease.

Ziad Ali, MD, explaines the impact of coronary intravascular lithotripsy (IVL) use in nodular and eccentric calcium morphologies at TCT 2023. IVL was found to produce better outcomes than atherectomy or high pressure balloons. #TCT #TCT2023 #TCT23 #IVL

IVL is safe and effective across all calcium morphologies, new research confirms

Ziad Ali, MD, detailed two studies he presented on coronary intravascular lithotripsy at TCT 2023 in San Francisco.

AI artificial intelligence stethoscope doctor

5 key criteria for AI prediction models in cardiology

AI-based prediction models have shown significant promise, but many are still flawed in a way that limits their value.

Newsweek ranked the 50 best heart hospitals in the world

Deaths from CVD are on the rise, cardiologists warn—high blood pressure, obesity remain 2 primary culprits

Cardiovascular disease remains one of the leading causes of mortality in the world, responsible for nearly 20 million deaths in 2022 alone.

Adolph M. Hutter, MD, cardiologist and past president of the American College of Cardiology

Beloved cardiologist remembered as a ‘master clinician’ and 'friend to all'

Adolph M. Hutter, MD, spent more than 50 years with Massachusetts General Hospital and worked with multiple professional sports teams. In addition, he served as president of the American College of Cardiology in 1992-1993.

Harlan M. Krumholz, MD, Yale American College of Cardiology

American College of Cardiology names renowned cardiologist the next editor-in-chief of its flagship journal

The publication's current editor-in-chief is Valentin Fuster, MD, PhD. Harlan M. Krumholz, MD, will begin his five-year term in 2024.

Dapagliflozin improves symptoms in some, but not all, heart failure patients

The popular SGLT2 inhibitor, sold under the brand name Farxiga, is approved by the FDA to treat heart failure, type 2 diabetes and CKD. Recent data on its ability to affect the symptoms of heart failure patients have been inconsistent.

Cardiac imaging expert Renee Bullock-Palmer, MD, explains how calcium scoring can determine if patients need to be on statins or not.

CT calcium scoring can determine if patients need statins

Renee Bullock-Palmer, MD, director, non-invasive cardiac imaging, at the Deborah Heart and Lung Center, explains CT calcium scoring can determine if a patient needs to take aspirin and statins for prevention of coronary disease.

Cardiology Associations

AI-based coronary plaque evaluations highlight elevated heart risks in women

Death after 1 year more common for real-world low-risk TAVR patients than those treated in clinical trials

No longer the ‘forgotten valve’: Tricuspid valve surgery outcomes keep improving

Implantable IVC sensor shows early potential to guide heart failure management

New drug reverses antiplatelet effects of ticagrelor, helping surgeons avoid a 'bloody mess'